Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filters

PublicationDisease areaApplication areaSample typeProducts

Eurasia Journal of Science and Technology, 2026
PLASMA PROTEIN LEVEL RATIOS IDENTIFY NOVEL CIRCULATING TARGETS ASSOCIATED WITH STROKE RISK

Wang Q., Jin T., Gu J. et al.

Olink Explore 3072/384CVDNeurologyPatient StratificationPlasma

Frontiers in Immunology, 2026
Serum immune profiling suggests overlap between IBD patients with joint complaints and patients with spondyloarthritis

Veltkamp S., van Gaalen F., de Bruin L. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum

Frontiers in Cell and Developmental Biology, 2026
A discovery protein panel for brain predicted age discordance using MRI in neurologically healthy individuals

Gill J., Lim A., Esopenko C. et al.

Olink Explore HTNeurologyAgingPatient StratificationPlasma

Scientific Reports, 2026
A case–control study of mid-pregnancy circulating cardiovascular proteins in women with subsequent preeclampsia and small for gestational age births

Callbo P., Junus K., Lindberger E. et al.

Olink Target 96ObstetricsGynecologyPathophysiologyPlasma

Frontiers in Medicine, 2026
Reanalysis of the immunological characteristics of scalp psoriasis: a cross-sectional study using Olink proteomics

Zhu L., Chen W., Shen N. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyTissue Lysate

Frontiers in Immunology, 2026
TLR7 signaling aggravates lung inflammation associated with increased anti-Scl-70 autoantibody production in murine bleomycin-induced systemic sclerosis

Evangelista J., Nisperuza Vidal A., Xu D. et al.

Olink Target 48Immunological & Inflammatory DiseasesPathophysiologyMouse Tissue Lysate

Inflammation Research, 2026
Pathway-level proteomics identifies subcellular trafficking dysregulation as a molecular signature in severe traumatic brain injury

Van Nynatten L., Tweddell D., Daley M. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma

Journal of Inflammation Research, 2026
Paired Tear Fluid – Plasma Inflammatory Profiling Identifies Compartment-Specific Biomarkers for Diabetic Retinopathy and Diabetic Macular Edema

Yu T., Li S., Cheng F. et al.

Olink Target 96Metabolic DiseasesOphthalmologyPatient StratificationPlasmaTear Fluid

Frontiers in Nephrology, 2026
Plasma proteomics based on machine learning predict the early risk of kidney outcomes in patients with DKD: a prospective cohort study from UK Biobank

Jiang L., Li T., Zhang H. et al.

Olink Explore 3072/384Metabolic DiseasesNephrologyPatient StratificationPlasma

eBioMedicine, 2026
Serum inflammatory proteomic signatures define chronic inflammatory demyelinating polyneuropathy and inform on disease activity

Bhandage A., Stascheit F., Preßler H. et al.

Olink Target 96RevealNeurologyPathophysiologyPatient StratificationSerum

Stem Cell Research & Therapy, 2026
Endothelial–immune cells-on-chip for multiplex evaluation of drug responses through patient plasma screening

Lee K., Wee H., Teng Z. et al.

Olink Target 48Technical StudiesTechnical EvaluationCell Culture Supernatant

British Journal of Cancer, 2026
Circulating tumor-associated autoantibody signatures for diagnosis and prognosis in small-cell lung cancer and lung adenocarcinoma

Liu C., Fukuda E., Sagiya Y. et al.

Olink Explore HTOncologyPatient StratificationPlasma

Nature Medicine, 2026
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling

Suissa D., Fidelle M., Reich E. et al.

Olink Explore 3072/384OncologyImmunotherapyPatient StratificationSerum

Journal of the American Academy of Dermatology, 2026
Ivarmacitinib is associated with rapid clinical improvement and immune remodeling in palmoplantar pustulosis: A multi-center, single-arm clinical trial

Xu Z., Chen W., Du J. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPatient StratificationPlasma

Nature Mental Health, 2026
Multi-omic signatures and trajectories of cardiometabolic diseases and depression

Yang G., Jiang X., Wang J. et al.

Olink Explore 3072/384Metabolic DiseasesCVDNeurologyPatient StratificationPlasma

Current Issues in Molecular Biology, 2026
Exploring the Relationship Between Protein-Level Ratios (rQLTs) and Duodenal Ulcer

Tang S., Li Y., Yu X. et al.

Olink Explore 3072/384GastroenterologyPathophysiologyPlasma

Neurology Neuroimmunology & Neuroinflammation, 2026
Immuno-Proteomic Features Associated to Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Gallaccio G., Müller A., Wang M. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesNeurologyPathophysiologySerumCSF

iScience, 2026
Immune hyperactivity in hemodialysis patients is associated with interferon gamma-induced trained immunity

Jonkman I., Jacobs M., Helder L. et al.

Olink Target 96NephrologyHematologyPathophysiologyPlasma

Cardiovascular Research, 2026
Associations of the inflammasome-dependent cytokine IL-18 with risk of coronary heart disease

Björkbacka H., Gonçalves I., Engström G. et al.

Olink Target 96Olink Explore 3072/384CVDPatient StratificationPlasma

International Journal of Cancer, 2026
Immune Markers and Risk of Pancreatic Cancer in the European EPIC Cohort

Katzke V., Chen Y., Dutta S. et al.

Olink Target 96OncologyPatient StratificationPlasmaSerum

4146 publications